Welcome
Support Centre
13 October 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
British stomach cancer group trial IV: A randomised trial of cimetidine treatment in gastric cancer
ISRCTN ISRCTN45115288
ClinicalTrials.gov identifier
Public title British stomach cancer group trial IV: A randomised trial of cimetidine treatment in gastric cancer
Scientific title
Acronym N/A
Serial number at source GA3004
Study hypothesis Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Oesophagus, stomach cancer
Participants - inclusion criteria 1. Biopsy proven adenocarcinoma of the stomach, any stage of disease, whether removed curatively or palliatively, or unresectable
2. Able to swallow tablets
3. No other concurrent cancer at other primary sites
4. No other serious illness, limiting prognosis severely
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/1994
Anticipated end date 31/03/1995
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Patients are randomised to one of four treatment arms:
1. Arm A: Cimetidine 400 mg twice daily until death.
2. Arm B: Cimetidine 400 mg once daily until death.
3. Arm C: Placebo tablet twice daily until death.
4. Arm D: Placebo tablet once daily until death.
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding 1. Cancer Research UK
2. Smithkline Beecham Pharmaceuticals
Trial website
Publications
Contact name Dr  -  -
  Address UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 20 7670 4723
  Fax +44 (0) 20 7670 4818
  Email register@ctu.mrc.ac.uk
Sponsor Cancer Research UK (CRUK) (UK)
  Address PO Box 123
Lincoln's Inn Fields
  City/town London
  Zip/Postcode WC2A 3PX
  Country United Kingdom
  Tel +44 (0)20 7317 5186
  Fax +44 (0)20 7487 4302
  Email kate.law@cancer.org.uk
  Sponsor website: http://www.cancer.org.uk
Date applied 01/07/2001
Last edited 22/05/2008
Date ISRCTN assigned 01/07/2001
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central